|
Sierra Neuropharmaceuticals |
|
|
12635 E. Montview Boulevard , Suite 131
Aurora, CO 80010 USA
phone:303-496-0141
fax:303-496-0141
|
|
| Symbol |
Private |
| Founded |
2005 |
| Employees |
|
|
|
| www.sierraneuro.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Catheter-Based Drug Delivery to Cerebrospinal Fluid |
|
| Management |
|
| |
|
|
| |
|
| Keywords |
| Drug Delivery, Neurology, Psychiatry, Anxiety Disorders, Bipolar Disorder, Depression, Epilepsy, Schizophrenia |
|
|
|
| Description |
|
Sierra Neuropharmaceuticals uses technology incorporating standard, subcutaneously implanted pumps in the direct delivery of drugs to the cerebrospinal fluid via catheter. This approach can help patients circumvent the side effects and toxic complications associated with oral therapies while increasing compliance. |
|
|
| Status |
| Sierra plans to commence clinical trials in 2010. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members